maxidex- dexamethasone sodium phosphate ointment

Šalis: Jungtinės Valstijos

kalba: anglų

Šaltinis: NLM (National Library of Medicine)

Veiklioji medžiaga:

dexamethasone sodium phosphate (UNII: AI9376Y64P) (dexamethasone phosphate - UNII:2BP70L44PR)

Prieinama:

Alcon

INN (Tarptautinis Pavadinimas):

dexamethasone sodium phosphate

Vaisto forma:

OINTMENT

Sudėtis:

0.5 mg in 1 g

Vartojimo būdas:

OPHTHALMIC

Recepto tipas:

PRESCRIPTION DRUG

Terapinės indikacijos:

Contraindicated in epithelial herpes simplex keratitis (dendritic keratitis); fungal diseases of ocular structures; acute infectious stages of vaccinia, varicella and many other viral disease of the cornea and conjunctiva; mycobacterial infection of the eye and in those persons who have shown hypersensitivity to any component of this preparation.

Produkto santrauka:

In 3.5g ophthalmic tubes. NDC 0065-0616-35 Store at 8° - 27°C (46° to 80°F). CAUTION: Federal (USA) law prohibits dispensing without prescription. ALCON® Ophthalmic Alcon Laboratories, Inc. Fort Worth, Texas  76134

Prekės savybės

MAXIDEX- DEXAMETHASONE SODIUM PHOSPHATE OINTMENT
ALCON
----------
DESCRIPTION
MAXIDEX®(Dexamethasone Sodium Phosphate) is an adrenocortical steroid
prepared as a sterile
ophthalmic ointment. The active ingredient is represented by the
chemical structure:
Established name:
Dexamethasone Sodium Phosphate
CHEMICAL NAME:
PREGN-4-ENE-3,20-DIONE,9-FLUORO-11,17-DIHYDROXY-16-METHYL-21-(PHOSPHONOXY)-,
DISODIUM SALT,
(11Β,16Α)-.
Each gram contains: ACTIVE: Dexamethasone Sodium Phosphate equivalent
to Dexamethasone Phosphate
0.5 mg (0.05%) INACTIVE: Mineral Oil.
White Petrolatum. DM-00
CLINICAL PHARMACOLOGY
Dexamethasone sodium phosphate suppresses the inflammatory response to
a variety of agents and it
probably delays or slows healing. No generally accepted explanation of
these steroid properties has
been advanced.
INDCIATIONS AND USAGE
Steroid responsive inflammatory conditions of the palpebral and bulbar
conjunctiva, cornea, and anterior
segment of the globe. These include allergic conjunctivitis, acne
rosacea, superficial punctate keratits,
herpes zoster keratitis, iritis, cyclitis, selected infective
conjunctivities when the inherent hazard of
steroid use is accepted to obtain an advisable diminution in edema and
inflammation; corneal injury from
chemical or thermal burns, or penetration of foreign bodies.
CONTRAININDICATIONS
Contraindicated in epithelial herpes simplex keratitis (dendritic
keratitis); fungal diseases of ocular
structures; acute infectious stages of vaccinia, varicella and many
other viral disease of the cornea and
conjunctiva; mycobacterial infection of the eye and in those persons
who have shown hypersensitivity to
any component of this preparation.
WARNINGS
Prolonged use may result in ocular hypertension and/or glaucoma, with
damage to the optic nerve,
defects in visual acuity and fields of vision, and posterior
subcapsular cataract formation. Prolonged
use may suppress the host response an thus increase the hazard of
secondary ocular infections. In those
diseases causing thinning of the cornea o